Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damian Tworek

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Pulmonary Pharmacology & Therapeutics|March 15, 2006
The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitisDamian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, et al.
Pneumonologia I Alergologia Polska|October 22, 2013
Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthmaIzabela Kupryś-Lipińska, Damian Tworek, Francis Vanderbist, et al.
Pneumonologia I Alergologia Polska|February 3, 2007
[Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study]Damian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, et al.
Pneumonologia I Alergologia Polska|April 12, 2007
[Lack of correlation between exhaled nitric oxide (eNO) and clinical indicators of the disease activity and quality of life in mild and moderate asthmatics]Damian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, et al.
American Journal of Rhinology & Allergy|May 3, 2013
Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitisDamian Tworek, Malgorzata Bochenska-Marciniak, Izabela Kuprys-Lipinska, et al.
Archives of Medical Science : AMS|November 26, 2013
MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitisDamian Tworek, Piotr Kuna, Wojciech Młynarski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|September 20, 2007
[The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma]Maciej Kupczyk, Ewa Bogacka, Małgorzata Bocheńska-Marciniak, et al.
The Clinical Respiratory Journal|August 9, 2019
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis: A pilot studySebastian Majewski, Damian Tworek, Karolina Szewczyk, et al.
Molecular Biology Reports|November 30, 2010
The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot studyTadeusz Pietras, Michał Panek, Damian Tworek, et al.
Vaccines|February 26, 2025
Safety and Efficacy of Influenza Vaccination in Kidney Graft Recipients in Late Period After Kidney TransplantationAnna Zawiasa-Bryszewska, Maja Nowicka, Monika Górska, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Pulmonary Pharmacology & Therapeutics|March 15, 2006
The effect of 4 weeks treatment with desloratadine (5mg daily) on levels of interleukin (IL)-4, IL-10, IL-18 and TGF beta in patients suffering from seasonal allergic rhinitisDamian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, et al.
Pneumonologia I Alergologia Polska|October 22, 2013
Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthmaIzabela Kupryś-Lipińska, Damian Tworek, Francis Vanderbist, et al.
Pneumonologia I Alergologia Polska|February 3, 2007
[Safety of venom immunotherapy in patients pretreated with antihistamines--a retrospective study]Damian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, et al.
Pneumonologia I Alergologia Polska|April 12, 2007
[Lack of correlation between exhaled nitric oxide (eNO) and clinical indicators of the disease activity and quality of life in mild and moderate asthmatics]Damian Tworek, Małgorzata Bocheńska-Marciniak, Maciej Kupczyk, et al.
American Journal of Rhinology & Allergy|May 3, 2013
Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitisDamian Tworek, Malgorzata Bochenska-Marciniak, Izabela Kuprys-Lipinska, et al.
Archives of Medical Science : AMS|November 26, 2013
MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitisDamian Tworek, Piotr Kuna, Wojciech Młynarski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|September 20, 2007
[The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma]Maciej Kupczyk, Ewa Bogacka, Małgorzata Bocheńska-Marciniak, et al.
The Clinical Respiratory Journal|August 9, 2019
Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis: A pilot studySebastian Majewski, Damian Tworek, Karolina Szewczyk, et al.
Molecular Biology Reports|November 30, 2010
The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot studyTadeusz Pietras, Michał Panek, Damian Tworek, et al.
Vaccines|February 26, 2025
Safety and Efficacy of Influenza Vaccination in Kidney Graft Recipients in Late Period After Kidney TransplantationAnna Zawiasa-Bryszewska, Maja Nowicka, Monika Górska, et al.
Pageof 3